Caitlin Elgarten, M.D. M.S.C.E.
Assistant Professor of Pediatrics (Oncology) at the Children's Hospital of Philadelphia
Attending Physician, Division of Oncology, Children’s Hospital of Philadelphia
Director, Supportive Care in Oncology Research (SCORe) Program, Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
HUB Center for Clinical Collaboration; 3528
3500 Civic Center Blvd
Philadelphia, PA 19104
HUB Center for Clinical Collaboration; 3528
3500 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 807-9038
Education
BA (Human Biology)
Brown University, 2006.
MD
Columbia University, 2011.
MSCE
University of Pennsylvania, 2018.
Permanent linkBA (Human Biology)
Brown University, 2006.
MD
Columbia University, 2011.
MSCE
University of Pennsylvania, 2018.
Selected Publications
Zheng DJ, Hettinger G, Aftandilian C, Bona K, Caywood EH, Collier AB, Elgarten CW, Gathers C, Ghosh T, Gramatges MM, Henry M, Huang YV, Li Y, Lotterman C, Maloney K, Mian A, Miller TP, Modi A, Mody R, Morgan E, Myers R, Newman H, Ortiz J, Seif AE, Smith C, Stokke J, Wang X, Winick N, Wilkes JJ, Wong V, Aplenc R, Getz KD: Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst 118(4), Apr 2026.Khawaja F, Elgarten CW: Intravenous Brincidofovir Effectively Reduces CMV Dnaemia In Antiviral Experienced Immunocompromised Patients: Results of a Phase 2a Clinical Trial Tandem Feb 2026.
Salomon AL, Ammann RA, Aftandilian C, Bochennek K, Brack E, Dupuis L, Elgarten CW, Esbenshade A, Haeusler GM, Karamatsu M, Moenster MB, Phillips B, Schaeffer E, Sung L, Tragiannidis A, Vissing NH, Koenig C: Association of Time to Antibiotics With Outcome in Pediatric Patients Receiving Chemotherapy for Cancer With Fever in Neutropenia—An International Individual Patient Data Meta-Analysis. Cancer Medicine 15(1): e71512, January 2026 Notes: https://doi.org/10.1002/cam4.71512.
Elgarten CW, Rheingold SR, Freedman JL: Management of Oncologic Emergencies. Lanzkowsky's Manual of Pediatric Hematology and Oncology 8th Edition, 2026.
Elgarten CW, Fisher BT, Aftandilian C: Management principles for neutropenic patients. Infectious Diseases in the Immunocompromised Child: Transplant, Oncology and Other Immune Compromising Conditions 2nd Edition, 2026.
Boulter A, Khuong QL, Tam V, Zheng D, Jung W, Huang Y S, Aftandilian C, Bona K, Elgarten C, Ghosh T, Gramatges M M, Maloney K, Mian A, Miller T, Mody R, Myers R, Seif A, Smith C, Stokke J, Vasanna S, Winick N, Wilkes J, Wong V, Fisher B, Li Y, Aplenc R, Getz K: Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed Acute Myeloid Leukemia. ASH Dec 2025.
Lind K, Berry A, Li Y, Liu H, Rubinstein J, Nguyen G, Fabrizio V, Hall A, Bhojwani D, Quigg T, Maude S, Shah N, Ortega M, Al-Mulla A, Ahmed I, Beck J, Bhatla D, Briscoe E, Chu R, Davis L, Dolan J G, Drinkwine J, Elias A, Elo L, Eom E, Faulk K, Goode E, Hamill D, Hammoud M S, Hinson A, Hoover A, Kinoshita H, Kohorst M, Krieger E, Lee-Miller C, McNerney K, Milner J, Moskop A, Moore-Higgs G, Murphy L, Murphy M, Patel H, Pfeiffer T, Prosser-Dombrowski A, Rahim M, Rahrig A, Saraf A, Shoag J, Symons H, Tastet N, Thomas S, Thornock M, Toner K, Vasanna S, Escobar Vasco A, Weisnicht A, Zarnegar-Lumley S, Winestone L, Myers R, Elgarten C: Survival after first relapse of pediatric B-ALL differs by insurance type: A real-world analysis from the recall-1 study. American Society of Hematology Dec 2025.
Elgarten C, Li Y, Xie Y, Wang L, Aftandilian C, Bona K, Ghosh T, Gramatges M M, Maloney K, Martin A, Miller T, Mody R, Smith C, Stokke J, Vasanna S, Wilkes J, Wong V, Myers R, Getz K, Aplenc R: Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1. ASH Annual Meeting Dec 2025.
Berry A, Elgarten C, Li Y, Liu H, Lind K, Zheng D, Nguyen G, Fabrizio V, Ortega M, Rubinstein J, Quigg T, Hall A, Bhojwani D, Shah N, Maude S, Zarnegar-Lumley S, Weisnicht A, Toner K, Thornock M, Thomas S, Tastet N, Symons H, Shoag J, Saraf A, Rahrig A, Rahim M, Prosser-Dombrowski A, Pfeiffer T, Patel H, Murphy M, Murphy L, Moskop A, Moore-Higgs G, Milner J, McNerney K, Lee-Miller C, Kohorst M, Kinoshita H, Krieger E, Vasanna S, Hoover A, Hinson A, Hammoud M S, Hamill D, Goode E, Faulk K, Escobar Vasco A, Elo L, Elias A, Eom E, Drinkwine J, Dolan J G, Davis L, Chu R, Briscoe E: Disparate post-relapse survival outcomes by race/ethnicity for children with B-cell acute lymphoblastic leukemia: An analysis from the recall-1 stud. ASH Dec 2025.
Khuong QL, Zheng D, Hettinger G, Elgarten C, Boulter A, Aftandilian C, Bona K, Ghosh T, Gramatges M M, Huang Y S, Maloney K, Mian A, Miller T, Vasanna S, Mody R, Myers R, Seif A, Smith C, Stokke J, Winick N, Wilkes J, Wong V, Fisher B, Ky B, Li Y, Aplenc R, Getz K: Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity. ASH Dec 2025.